Stay updated with breaking news from Athersys Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Research analysts at StockNews.com assumed coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a report issued on Thursday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Athersys Price Performance ATHX stock opened at $0.02 on Thursday. Athersys has a twelve month low of $0.01 and a twelve month high […]
This exploratory analysis of the SELECT2 trial assesses the relationship between imaging estimates of irreversibly injured brain (core) and at-risk regions (mis
/PRNewswire/ -- The hematopoietic stem cells transplantation (HSCT) market size is estimated to increase by USD 2.38 billion from 2023 to 2027, with a CAGR of...
StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a report released on Tuesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Athersys Price Performance ATHX stock opened at $0.02 on Tuesday. Athersys has a 52 week low of $0.01 and a 52 week high of $1.99. The […]
StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report report published on Tuesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Athersys Stock Performance Shares of NASDAQ:ATHX opened at $0.02 on Tuesday. The company’s fifty day moving average is $0.02 and its two-hundred day moving […]